{"hands_on_practices": [{"introduction": "Prognostication in cirrhosis is crucial for clinical decision-making, and the Child-Pugh score remains a foundational tool for this purpose. It elegantly combines laboratory markers of hepatic function with the clinical severity of portal hypertension's major consequences. This practice will hone your ability to calculate this score, a critical skill for rapidly assessing patient risk and guiding management strategies. [@problem_id:4812915]", "problem": "A patient with established cirrhosis presents for risk stratification and management planning. From the core definitions of hepatic synthetic and excretory function and the clinical manifestations of portal hypertension, delineate the five components that constitute the Child–Pugh score (CPS) and the categorical grading scheme that stratifies severity based on the total points. Then, compute the CPS numeric score for the following hypothetical patient. The patient is a $58$-year-old individual with cirrhosis due to chronic hepatitis C virus infection, who has the following data at the time of assessment: total bilirubin $3.2\\,\\mathrm{mg/dL}$, serum albumin $2.9\\,\\mathrm{g/dL}$, International Normalized Ratio (INR) $2.1$, clinically moderate ascites controlled with diuretics, and hepatic encephalopathy of grade $\\mathrm{II}$ (intermittent confusion requiring lactulose therapy). Report the Child–Pugh numeric score as a unitless integer (no rounding needed). Do not convert any units; use the provided values as stated.", "solution": "### Solution\n\nThe Child-Pugh score, also known as the Child-Turcotte-Pugh (CTP) score, is a prognostic tool used to assess the severity of chronic liver disease, primarily cirrhosis. It quantifies the degree of hepatic dysfunction and is predictive of patient survival and the risk of complications, including mortality following major surgery. The score is calculated based on five clinical and laboratory parameters.\n\nThe five components of the Child-Pugh score are:\n1.  **Total Bilirubin**: A measure of hepatic excretory function. Hyperbilirubinemia indicates impaired conjugation and/or excretion of bilirubin.\n2.  **Serum Albumin**: A measure of hepatic synthetic function. Hypoalbuminemia reflects reduced protein synthesis by the liver.\n3.  **International Normalized Ratio (INR)**: A standardized measure of the prothrombin time, reflecting the liver's ability to synthesize coagulation factors $\\mathrm{II}$, $\\mathrm{V}$, $\\mathrm{VII}$, and $\\mathrm{X}$. An elevated INR indicates impaired synthetic function. The INR is a modern modification, replacing the original parameter of prothrombin time prolongation.\n4.  **Ascites**: The accumulation of fluid in the peritoneal cavity, a major complication of portal hypertension. Its severity is graded clinically.\n5.  **Hepatic Encephalopathy (HE)**: A spectrum of neuropsychiatric abnormalities in patients with liver dysfunction, caused by the accumulation of neurotoxins (e.g., ammonia) that are normally cleared by the liver.\n\nEach component is assigned a score of $1$, $2$, or $3$ points based on its severity, as detailed in the following table.\n\n| Parameter | 1 Point | 2 Points | 3 Points |\n| :--- | :--- | :--- | :--- |\n| Total Bilirubin ($\\mathrm{mg/dL}$) | $ 2$ | $2 - 3$ | $ 3$ |\n| Serum Albumin ($\\mathrm{g/dL}$) | $ 3.5$ | $2.8 - 3.5$ | $ 2.8$ |\n| INR | $ 1.7$ | $1.7 - 2.3$ | $ 2.3$ |\n| Ascites | None | Mild / Diuretic-responsive | Moderate-to-Severe / Diuretic-refractory |\n| Hepatic Encephalopathy | None (Grade $0$) | Grade $\\mathrm{I}$ - $\\mathrm{II}$ (or minimal) | Grade $\\mathrm{III}$ - $\\mathrm{IV}$ (or advanced) |\n\nAfter summing the points from all five components, the total score is used to stratify patients into one of three severity classes, which correlate with one- and two-year survival rates.\n\n**Child-Pugh Class Stratification**\n- **Class A**: $5-6$ points (Least severe liver disease)\n- **Class B**: $7-9$ points (Moderately severe liver disease)\n- **Class C**: $10-15$ points (Most severe liver disease)\n\nNow, we compute the Child-Pugh score for the given patient.\n\n1.  **Total Bilirubin**: The patient's value is $3.2\\,\\mathrm{mg/dL}$. Since this value is greater than $3$, it corresponds to $3$ points.\n    $$ \\text{Bilirubin Score} = 3 $$\n\n2.  **Serum Albumin**: The patient's value is $2.9\\,\\mathrm{g/dL}$. This falls within the range of $2.8 - 3.5$, corresponding to $2$ points.\n    $$ \\text{Albumin Score} = 2 $$\n\n3.  **International Normalized Ratio (INR)**: The patient's value is $2.1$. This falls within the range of $1.7 - 2.3$, corresponding to $2$ points.\n    $$ \\text{INR Score} = 2 $$\n\n4.  **Ascites**: The patient is described as having \"clinically moderate ascites controlled with diuretics\". In contemporary scoring systems, diuretic-responsive ascites, regardless of being subjectively termed \"moderate\", is typically classified as grade $2$. Grade $3$ is reserved for severe or diuretic-refractory ascites. This interpretation aligns with the functional severity of the condition. Therefore, this finding corresponds to $2$ points.\n    $$ \\text{Ascites Score} = 2 $$\n\n5.  **Hepatic Encephalopathy**: The patient has Grade $\\mathrm{II}$ HE. This falls into the Grade $\\mathrm{I}$ - $\\mathrm{II}$ category, corresponding to $2$ points.\n    $$ \\text{Encephalopathy Score} = 2 $$\n\nThe total Child-Pugh score is the sum of the points for each of the five components.\n$$ \\text{Total Score} = (\\text{Bilirubin}) + (\\text{Albumin}) + (\\text{INR}) + (\\text{Ascites}) + (\\text{Encephalopathy}) $$\n$$ \\text{Total Score} = 3 + 2 + 2 + 2 + 2 = 11 $$\nA score of $11$ places the patient in Child-Pugh Class C, indicating severe liver disease and a poor prognosis. The problem asks only for the numeric score.", "answer": "$$\\boxed{11}$$", "id": "4812915"}, {"introduction": "Altered mental status in a patient with cirrhosis represents a critical diagnostic and therapeutic challenge, often stemming from an overlap of life-threatening conditions. This scenario requires you to differentiate among hepatic encephalopathy, sepsis, and Wernicke’s encephalopathy, all while initiating time-sensitive treatments. This practice sharpens your clinical judgment in prioritizing actions when facing a complex, decompensated patient. [@problem_id:4812903]", "problem": "A patient with advanced liver disease presents with altered mental status. A $54$-year-old man with alcohol-associated cirrhosis complicated by ascites and prior variceal bleeding is brought to the emergency department after $2$ days of progressive confusion and unsteady gait. He has had poor oral intake. Medications include furosemide and spironolactone; adherence to lactulose is uncertain. He denies head trauma. On examination, he is somnolent but arousable, disoriented, and has asterixis. He has scleral icterus and a distended, tender abdomen with a fluid wave. Neurologic examination reveals horizontal nystagmus and mild truncal ataxia without focal weakness. Vital signs are: temperature $38.6^\\circ\\mathrm{C}$, heart rate $108/\\mathrm{min}$, blood pressure $96/58\\,\\mathrm{mmHg}$, respiratory rate $24/\\mathrm{min}$, oxygen saturation $95\\%$ on room air. Initial laboratory studies show: serum sodium $128\\,\\mathrm{mEq/L}$, potassium $3.1\\,\\mathrm{mEq/L}$, creatinine $1.7\\,\\mathrm{mg/dL}$, total bilirubin $4.2\\,\\mathrm{mg/dL}$, international normalized ratio (INR) $1.8$, platelets $72{,}000/\\mu\\mathrm{L}$, white blood cells $14{,}600/\\mu\\mathrm{L}$. You are considering hepatic encephalopathy (HE), Wernicke’s encephalopathy (WE), and sepsis due to spontaneous bacterial peritonitis (SBP) as drivers of his mental status change. Appropriate diagnostic tools might include an electroencephalogram (EEG), Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) of the brain, and diagnostic abdominal paracentesis.\n\nWhich of the following immediate bundles of actions best operationalizes a focused diagnostic workup to discriminate among HE, WE, and sepsis while simultaneously initiating time-critical, evidence-based therapy in this patient?\n\nA. Start lactulose and rifaximin and send a serum ammonia level to confirm hepatic encephalopathy; obtain emergent noncontrast head CT and electroencephalogram; withhold antibiotics and thiamine until after neuroimaging; defer paracentesis due to elevated INR.\n\nB. Administer intravenous thiamine before any glucose-containing fluids; start empiric intravenous antibiotics targeting spontaneous bacterial peritonitis (for example, cefotaxime or ceftriaxone); obtain blood and urine cultures and a serum lactate; perform immediate bedside diagnostic paracentesis with cell count, differential, and culture; obtain a chest radiograph; initiate lactulose titrated to achieve at least $3$ soft bowel movements per day and correct hypokalemia; avoid routine head CT in the absence of focal neurologic deficits or trauma; reserve MRI and EEG for encephalopathy refractory to initial measures.\n\nC. Give an intravenous bolus of dextrose for suspected Wernicke’s encephalopathy followed by oral thiamine; avoid lactulose until a serum ammonia level is proven elevated; defer paracentesis because of coagulopathy; initiate broad-spectrum antibiotics only if procalcitonin is elevated.\n\nD. Start high-dose corticosteroids for presumed alcoholic hepatitis–related encephalopathy; schedule urgent endoscopy to exclude variceal bleeding and a CT scan of the abdomen and pelvis; stop diuretics; do not administer antibiotics or thiamine until a definitive diagnosis is established; rely on a venous ammonia level to distinguish hepatic encephalopathy from other causes.", "solution": "### Principle-Based Derivation\n\nThe patient is critically ill, with evidence suggesting at least three co-existing or competing diagnoses: sepsis (likely from SBP), Wernicke's encephalopathy (WE), and hepatic encephalopathy (HE). The optimal management strategy must address all three possibilities simultaneously, prioritizing interventions for the most imminently life-threatening conditions.\n\n1.  **Sepsis / Spontaneous Bacterial Peritonitis (SBP):** The patient meets criteria for sepsis, with fever ($38.6^\\circ\\mathrm{C}$), tachycardia ($108/\\mathrm{min}$), tachypnea ($24/\\mathrm{min}$), hypotension ($96/58\\,\\mathrm{mmHg}$), altered mental status, and leukocytosis ($14{,}600/\\mu\\mathrm{L}$). The presence of ascites and abdominal tenderness makes SBP the most likely source. Sepsis is a medical emergency with high mortality if treatment is delayed.\n    -   **Action:** Immediate administration of empiric intravenous antibiotics is required, ideally after drawing blood cultures. A third-generation cephalosporin (e.g., cefotaxime, ceftriaxone) is a standard first-line choice for SBP.\n    -   **Diagnosis:** Immediate diagnostic paracentesis is mandatory to confirm SBP by analyzing the ascitic fluid for cell count and differential (a polymorphonuclear leukocyte count $\\ge250/\\mathrm{mm}^3$ is diagnostic). The elevated INR ($1.8$) and thrombocytopenia ($72{,}000/\\mu\\mathrm{L}$) are common in cirrhosis and are **not** contraindications to paracentesis; the benefit of diagnosing SBP far outweighs the very small risk of procedure-related bleeding.\n\n2.  **Wernicke’s Encephalopathy (WE):** The patient has a history of alcohol-associated cirrhosis and poor nutrition, placing him at high risk for thiamine deficiency. He exhibits the classic clinical triad for WE: encephalopathy (confusion), oculomotor dysfunction (horizontal nystagmus), and gait ataxia (truncal ataxia).\n    -   **Action:** WE is a clinical diagnosis and a neurological emergency. Treatment with high-dose parenteral (intravenous) thiamine should be initiated immediately. A critical principle is that **thiamine must be administered *before* any glucose-containing solutions**, as glucose metabolism consumes thiamine and can precipitate or acutely worsen WE in a deficient individual.\n\n3.  **Hepatic Encephalopathy (HE):** The patient has known cirrhosis and classic signs of HE (disorientation, asterixis). HE is often precipitated by factors such as infection (SBP), electrolyte disturbances, or renal dysfunction, all of which are present here.\n    -   **Action:** HE is a diagnosis of exclusion. While treating the presumed precipitants (infection), standard therapy with lactulose should be initiated to reduce ammonia absorption from the gut. The goal is typically titration to $2$-$3$ soft bowel movements per day. Correction of hypokalemia ($3.1\\,\\mathrm{mEq/L}$) is also important, as hypokalemia increases renal ammonia production, worsening HE.\n    -   **Diagnosis:** Serum ammonia levels correlate poorly with the severity of HE and are not required to make the diagnosis or initiate treatment. Treatment should not be delayed pending this result.\n\n4.  **Neuroimaging:** An emergent non-contrast head CT is used to rule out structural causes of altered mental status, such as an intracranial bleed. While often performed for completeness, it is of lower priority than administering antibiotics and thiamine in a patient with no history of trauma, no focal neurological deficits, and a clear infectious/metabolic picture. It should not delay life-saving therapies.\n\n**Summary of Optimal Immediate Actions:**\n-   Administer IV thiamine.\n-   Obtain blood, urine, and ascitic fluid cultures.\n-   Administer empiric IV antibiotics.\n-   Perform immediate diagnostic paracentesis.\n-   Initiate lactulose.\n-   Begin correction of hypokalemia.\n-   The full sepsis workup should also include a serum lactate and chest radiograph.\n\n### Option-by-Option Analysis\n\n**A. Start lactulose and rifaximin and send a serum ammonia level to confirm hepatic encephalopathy; obtain emergent noncontrast head CT and electroencephalogram; withhold antibiotics and thiamine until after neuroimaging; defer paracentesis due to elevated INR.**\nThis option contains multiple critical errors. It improperly relies on a serum ammonia level. Most dangerously, it withholds time-critical therapies (antibiotics for sepsis, thiamine for WE) and defers the key diagnostic procedure for SBP (paracentesis) based on a flawed understanding of contraindications. This approach would likely lead to significant harm.\n**Verdict:** **Incorrect**.\n\n**B. Administer intravenous thiamine before any glucose-containing fluids; start empiric intravenous antibiotics targeting spontaneous bacterial peritonitis (for example, cefotaxime or ceftriaxone); obtain blood and urine cultures and a serum lactate; perform immediate bedside diagnostic paracentesis with cell count, differential, and culture; obtain a chest radiograph; initiate lactulose titrated to achieve at least $3$ soft bowel movements per day and correct hypokalemia; avoid routine head CT in the absence of focal neurologic deficits or trauma; reserve MRI and EEG for encephalopathy refractory to initial measures.**\nThis option is a textbook example of best practices. It correctly prioritizes the immediate threats of WE (IV thiamine before glucose) and sepsis/SBP (cultures, empiric antibiotics, immediate paracentesis). It initiates appropriate therapy for HE (lactulose) and addresses a contributing factor (hypokalemia). It correctly contextualizes the role of diagnostic imaging (CT/MRI/EEG) as secondary to these immediate life-saving interventions in this specific clinical scenario.\n**Verdict:** **Correct**.\n\n**C. Give an intravenous bolus of dextrose for suspected Wernicke’s encephalopathy followed by oral thiamine; avoid lactulose until a serum ammonia level is proven elevated; defer paracentesis because of coagulopathy; initiate broad-spectrum antibiotics only if procalcitonin is elevated.**\nThis option is deeply flawed. Administering dextrose before thiamine is contraindicated. Oral thiamine is insufficient for treating acute WE. Deferring paracentesis is incorrect. Withholding lactulose pending an ammonia level is inappropriate. Using procalcitonin as the sole gatekeeper for antibiotics in suspected SBP is not the standard of care and is unsafe.\n**Verdict:** **Incorrect**.\n\n**D. Start high-dose corticosteroids for presumed alcoholic hepatitis–related encephalopathy; schedule urgent endoscopy to exclude variceal bleeding and a CT scan of the abdomen and pelvis; stop diuretics; do not administer antibiotics or thiamine until a definitive diagnosis is established; rely on a venous ammonia level to distinguish hepatic encephalopathy from other causes.**\nThis option is also dangerous. Starting corticosteroids in a patient with clear signs of infection is contraindicated and could be fatal. Withholding antibiotics and thiamine until a \"definitive diagnosis\" is obtained violates the principles of emergency medicine. Urgent endoscopy is not indicated in the absence of active bleeding. Relying on an ammonia level is incorrect. While stopping diuretics is a reasonable consideration, it is a minor point in a sequence of major, life-threatening errors.\n**Verdict:** **Incorrect**.", "answer": "$$\\boxed{B}$$", "id": "4812903"}, {"introduction": "Preventing rebleeding after an initial variceal hemorrhage is a cornerstone of management, and preemptive Transjugular Intrahepatic Portosystemic Shunt (TIPS) has emerged as a key intervention for high-risk patients. This strategy relies on principles of evidence-based medicine, demanding both careful patient selection using risk-stratification criteria and a quantitative understanding of the intervention's benefit. This problem will test your ability to apply clinical trial data to a practical decision, determining not only who is a candidate for early TIPS but also the expected magnitude of risk reduction. [@problem_id:4812993]", "problem": "A patient cohort with cirrhosis presents with acute esophageal variceal hemorrhage. Standard-of-care management consists of vasoactive agents, prophylactic antibiotics, and endoscopic band ligation, followed by secondary prophylaxis with nonselective beta blockade and repeat ligation. You are asked to identify which patients meet criteria for preemptive transjugular intrahepatic portosystemic shunt (TIPS) and to quantify the expected reduction in rebleeding if early TIPS is applied. The determination should be grounded in the following well-tested facts and definitions: (i) the Child–Turcotte–Pugh score classifies severity of cirrhosis, with Child–Pugh class $\\mathrm{C}$ defined by a total score of $10$ to $15$ points and Child–Pugh class $\\mathrm{B}$ defined by $7$ to $9$ points; (ii) “active bleeding” at endoscopy denotes ongoing spurting or oozing from varices at the time of endoscopic evaluation; (iii) in high-risk bleeders managed with standard therapy alone, the $1$-year rebleeding risk commonly approximates $50\\%$; and (iv) randomized controlled trials demonstrate that preemptive TIPS in high-risk bleeders reduces rebleeding risk with a relative risk on the order of $RR \\approx 0.20$ compared with standard therapy. Based on first principles, including risk ratio definitions and the clinical classification above, choose the option that most accurately defines criteria for early TIPS and correctly computes the expected absolute and relative reduction in rebleeding at $1$ year if early TIPS is used.\n\nWhich option is most accurate?\n\nA. Early TIPS is indicated for Child–Pugh class $\\mathrm{C}$ with scores $10$–$13$ or class $\\mathrm{B}$ with active bleeding on endoscopy, applied within $24$–$72$ hours of hemorrhage control. With standard therapy rebleeding risk $p_0 = 50\\%$ and $RR = 0.20$, the expected TIPS rebleeding risk is $p_1 = RR \\times p_0 = 10\\%$, yielding an absolute risk reduction of $40\\%$ and a relative risk reduction of $80\\%$.\n\nB. Early TIPS is indicated for Child–Pugh class $\\mathrm{C}$ with scores $14$–$15$ or class $\\mathrm{A}$ with active bleeding, applied after failure of endoscopic therapy. With $p_0 = 50\\%$ and $RR = 0.50$, the expected TIPS rebleeding risk is $25\\%$, absolute risk reduction $25\\%$, and relative risk reduction $50\\%$.\n\nC. Early TIPS is indicated only after rebleeding occurs despite optimal band ligation and pharmacotherapy, irrespective of Child–Pugh class or endoscopic activity. With $p_0 = 50\\%$ and $RR = 0.90$, the expected TIPS rebleeding risk is $45\\%$, absolute risk reduction $5\\%$, and relative risk reduction $10\\%$.\n\nD. Early TIPS should be offered to all patients with variceal hemorrhage regardless of Child–Pugh class or endoscopic findings. With $p_0 = 50\\%$ and $RR = 0.35$, the expected TIPS rebleeding risk is $17.5\\%$, absolute risk reduction $32.5\\%$, and relative risk reduction $65\\%$.", "solution": "### Solution Derivation\nThe problem requires two components: (1) identifying the correct clinical criteria for early/preemptive TIPS and (2) performing the correct biostatistical calculations based on the provided data.\n\n**Biostatistical Calculations**\nFirst, let's define the terms and calculate the risk reductions based on the provided facts.\n-   The risk of rebleeding at $1$ year in the control group (standard therapy) is given as $p_0 = 50\\% = 0.50$.\n-   The relative risk ($RR$) of rebleeding for the intervention group (early TIPS) compared to the control group is given as $RR = 0.20$.\n\nThe relative risk is defined as the ratio of the risk in the intervention group ($p_1$) to the risk in the control group ($p_0$):\n$$RR = \\frac{p_1}{p_0}$$\nWe can calculate the risk of rebleeding in the early TIPS group ($p_1$):\n$$p_1 = RR \\times p_0 = 0.20 \\times 0.50 = 0.10$$\nSo, the expected rebleeding risk with early TIPS is $10\\%$.\n\nThe Absolute Risk Reduction ($ARR$) is the difference in risk between the control and intervention groups:\n$$ARR = p_0 - p_1 = 0.50 - 0.10 = 0.40$$\nThis corresponds to an absolute risk reduction of $40\\%$.\n\nThe Relative Risk Reduction ($RRR$) is the proportional reduction in risk in the intervention group relative to the control group. It can be calculated in two ways:\n1.  As a function of the absolute risk reduction:\n    $$RRR = \\frac{ARR}{p_0} = \\frac{p_0 - p_1}{p_0} = \\frac{0.40}{0.50} = 0.80$$\n2.  As a function of the relative risk:\n    $$RRR = 1 - RR = 1 - 0.20 = 0.80$$\nBoth methods yield a relative risk reduction of $80\\%$.\n\n**Clinical Criteria for Preemptive TIPS**\nThe problem asks for the criteria for *preemptive* (or *early*) TIPS. This is a specific strategy applied to *high-risk* patients shortly after their initial bleeding episode is controlled, to prevent rebleeding. It is distinct from *rescue* TIPS (for bleeding uncontrolled by endoscopy) or TIPS for *secondary prophylaxis failure* (after a rebleeding event has already occurred on standard secondary prophylaxis). The evidence-based criteria for defining \"high-risk\" patients who benefit from preemptive TIPS are:\n-   Patients with Child–Pugh class C cirrhosis, but excluding the most severely ill (typically scores of $10$–$13$). Patients with scores $14$–$15$ were often excluded from trials due to prohibitive operative mortality and poor prognosis.\n-   Patients with Child–Pugh class B cirrhosis who have persistent bleeding at the initial endoscopy (\"active bleeding\" as defined in the problem).\nThis intervention is typically performed within $24$–$72$ hours of initial diagnosis and hemorrhage control.\n\n### Option-by-Option Analysis\nNow, I will evaluate each option against the derived solution.\n\n**A. Early TIPS is indicated for Child–Pugh class $\\mathrm{C}$ with scores $10$–$13$ or class $\\mathrm{B}$ with active bleeding on endoscopy, applied within $24$–$72$ hours of hemorrhage control. With standard therapy rebleeding risk $p_0 = 50\\%$ and $RR = 0.20$, the expected TIPS rebleeding risk is $p_1 = RR \\times p_0 = 10\\%$, yielding an absolute risk reduction of $40\\%$ and a relative risk reduction of $80\\%$.**\n-   **Clinical Criteria:** The stated criteria (Child–Pugh C with scores $10$–$13$ or Child–Pugh B with active bleeding) and timing ($24$–$72$ hours) are precisely the correct, evidence-based indications for preemptive TIPS.\n-   **Calculations:** The use of $p_0 = 50\\%$ and $RR = 0.20$ is consistent with the problem statement. The calculated values—$p_1 = 10\\%$, absolute risk reduction of $40\\%$, and relative risk reduction of $80\\%$—are all correct as derived above.\n-   **Verdict:** **Correct**.\n\n**B. Early TIPS is indicated for Child–Pugh class $\\mathrm{C}$ with scores $14$–$15$ or class $\\mathrm{A}$ with active bleeding, applied after failure of endoscopic therapy. With $p_0 = 50\\%$ and $RR = 0.50$, the expected TIPS rebleeding risk is $25\\%$, absolute risk reduction $25\\%$, and relative risk reduction $50\\%$.**\n-   **Clinical Criteria:** These are incorrect. Patients with Child–Pugh scores $14$–$15$ are generally considered too ill for this procedure preemptively. Child–Pugh class A patients are low-risk and not candidates for preemptive TIPS. \"After failure of endoscopic therapy\" describes rescue TIPS, not preemptive TIPS.\n-   **Calculations:** The assumed $RR=0.50$ contradicts fact (iv) of the problem statement, which gives $RR \\approx 0.20$. All subsequent calculations are based on this incorrect premise.\n-   **Verdict:** **Incorrect**.\n\n**C. Early TIPS is indicated only after rebleeding occurs despite optimal band ligation and pharmacotherapy, irrespective of Child–Pugh class or endoscopic activity. With $p_0 = 50\\%$ and $RR = 0.90$, the expected TIPS rebleeding risk is $45\\%$, absolute risk reduction $5\\%$, and relative risk reduction $10\\%$.**\n-   **Clinical Criteria:** This describes TIPS for secondary prophylaxis failure, which is a different indication from *preemptive* TIPS. Preemptive TIPS is applied before the first rebleed.\n-   **Calculations:** The assumed $RR=0.90$ contradicts fact (iv) of the problem statement ($RR \\approx 0.20$). All subsequent calculations are based on this incorrect premise.\n-   **Verdict:** **Incorrect**.\n\n**D. Early TIPS should be offered to all patients with variceal hemorrhage regardless of Child–Pugh class or endoscopic findings. With $p_0 = 50\\%$ and $RR = 0.35$, the expected TIPS rebleeding risk is $17.5\\%$, absolute risk reduction $32.5\\%$, and relative risk reduction $65\\%$.**\n-   **Clinical Criteria:** This is incorrect and dangerous medical advice. TIPS is a high-risk procedure and is not indicated for all patients. Low-risk patients (e.g., Child-Pugh A) do not have a favorable risk-benefit ratio for this intervention. The entire purpose of the clinical trials was to risk-stratify patients.\n-   **Calculations:** The assumed $RR=0.35$ contradicts fact (iv) of the problem statement ($RR \\approx 0.20$). All subsequent calculations are based on this incorrect premise.\n-   **Verdict:** **Incorrect**.", "answer": "$$\\boxed{A}$$", "id": "4812993"}]}